Identifying Clinicopathological Factors Associated with Oncotype DX<sup>®</sup> 21-Gene Recurrence Score: A Real-World Retrospective Cohort Study of Breast Cancer Patients in Quebec City, Canada

Identifying Clinicopathological Factors Associated with Oncotype DX<sup>®</sup> 21-Gene Recurrence Score: A Real-World Retrospective Cohort Study of Breast Cancer Patients in Quebec City, Canada

Gene expression profiling tests such as the Oncotype DX (ODX) 21-gene recurrence score (RS) assay is increasingly used in clinical practice to predict the risk of recurrence and support treatment planning for early-stage breast cancer (BC). However, this test has some disadvantages such as a high co...

Full description

Bibliographic Details
Main Authors: Simon Gagnet, Caroline Diorio, Louise Provencher, Cynthia Mbuya-Bienge, Julie Lapointe, Claudya Morin, Julie Lemieux, Hermann Nabi
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Journal of Personalized Medicine
Subjects:
adjuvant chemotherapy
breast cancer subtype
cancer recurrence risk score
clinical decision making
gene expression profiling
lifestyle risk factors
Online Access:https://www.mdpi.com/2075-4426/11/9/858

Internet

https://www.mdpi.com/2075-4426/11/9/858

Similar Items